GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Vietnamese Biotech Inc (HSTC:AMV) » Definitions » EBITDA Margin %

American Vietnamese Biotech (HSTC:AMV) EBITDA Margin % : 0.00% (As of . 20)


View and export this data going back to 2009. Start your Free Trial

What is American Vietnamese Biotech EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. American Vietnamese Biotech's EBITDA for the three months ended in . 20 was ₫0.00 Mil. American Vietnamese Biotech's Revenue for the three months ended in . 20 was ₫0.00 Mil. Therefore, American Vietnamese Biotech's EBITDA margin for the quarter that ended in . 20 was 0.00%.


American Vietnamese Biotech EBITDA Margin % Historical Data

The historical data trend for American Vietnamese Biotech's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Vietnamese Biotech EBITDA Margin % Chart

American Vietnamese Biotech Annual Data
Trend
EBITDA Margin %

American Vietnamese Biotech Quarterly Data
EBITDA Margin %

Competitive Comparison of American Vietnamese Biotech's EBITDA Margin %

For the Biotechnology subindustry, American Vietnamese Biotech's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Vietnamese Biotech's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Vietnamese Biotech's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where American Vietnamese Biotech's EBITDA Margin % falls into.



American Vietnamese Biotech EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

American Vietnamese Biotech's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

American Vietnamese Biotech's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


American Vietnamese Biotech  (HSTC:AMV) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


American Vietnamese Biotech EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of American Vietnamese Biotech's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


American Vietnamese Biotech (HSTC:AMV) Business Description

Traded in Other Exchanges
N/A
Address
20 Road 13, Block DC Song Da, Thu Duc Ward, Ho Chi Minh, VNM
American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments and chemicals; producing and trading vaccines and medical biological products; real estate business and financial investment.

American Vietnamese Biotech (HSTC:AMV) Headlines

From GuruFocus

Atlis Motor Vehicles to Present Strategies to Build and Expand Charging Infrastructure

By Stock market mentor Stock market mentor 01-19-2023